CARRIE O'CONNELL: Open Payments
NPI 1558028852 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 68 payments from 10 companies in 2025. Trend: 2023 $742 · 2024 $661 · 2025 $1,137
Food & beverage: $1,025Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $305 |
| Teva Pharmaceuticals USA, Inc. | 11 | $267 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $211 |
| Lundbeck LLC | 5 | $85 |
| ABBVIE INC. | 4 | $71 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 3 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: CAPLYTA, ARISTADA, REXULTI, LYBALVI, UZEDY, VRAYLAR, AUSTEDO XR, INGREZZA.
Industry payments across IA — which companies pay providers there.
